Caladrius Biosciences Inc...

NASDAQ: CLBS · Real-Time Price · USD
0.43
-0.08 (-16.05%)
At close: Sep 15, 2022, 6:00 AM

Caladrius Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Cash & Equivalents
94.97M
Short-Term Investments
151K
Long-Term Investments
n/a
Other Long-Term Assets
764K
Receivables
n/a
Inventory
n/a
Other Current Assets
-151K
Total Current Assets
94.97M
Property-Plant & Equipment
62K
Goodwill & Intangibles
n/a
Total Long-Term Assets
826K
Total Assets
97.01M
Account Payables
1.93M
Deferred Revenue
n/a
Short-Term Debt
n/a
Other Current Liabilities
2.59M
Total Current Liabilities
4.52M
Long-Term Debt
n/a
Other Long-Term Liabilities
485K
Total Long-Term Liabilities
485K
Total Liabilities
5.01M
Total Debt
n/a
Common Stock
60K
Retained Earnings
-453.02M
Comprehensive Income
-70K
Shareholders Equity
92M
Total Investments
151K